Urology / Nephrology News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
30 Jul 2010 at 6:00am
Russells Hall Hospital, part of The Dudley Group of Hospitals NHS Foundation Trust, is benefiting from greater efficiency in renal patient management with the installation of new specialist software. The eMEDRenal application from Mediqal H.I. was installed as part of Dudley's 15-year IT services Managed Equipment Service (MES) agreement with Siemens Healthcare. Siemens Healthcare and Mediqal H...
30 Jul 2010 at 4:00am
Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that physicians should individualize blood sugar targets for these patients and not rely on recommendations based on studies in the general population...
30 Jul 2010 at 4:00am
Reduced kidney function and protein in the urine place a person at risk for kidney injury, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The results suggest that improved recognition of these warning signs could help reduce preventable forms of acute kidney injury (AKI)...
30 Jul 2010 at 3:00am
UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease...
30 Jul 2010 at 3:00am
Surgeons at the University of California, San Diego School of Medicine continue to advance minimally-invasive surgery for cancer patients by reducing the number of abdominal incisions from approximately six to a single small incision...
30 Jul 2010 at 3:00am
Scientists at deCODE genetics and colleagues at Radboud University in the Netherlands describe how the impact of a single letter variation in the sequence of the human genome (SNP) conferring risk of kidney disease varies with age and with the onset of other diseases...
29 Jul 2010 at 7:00am
With a recent first of its kind surgery, physicians at Mayo Clinic in Arizona have developed a new surgical procedure for the treatment of prostate cancer using natural orifices - signaling the next step in the evolution of minimally invasive surgery. Removing the prostate is a common treatment for patients with prostate cancer, which affects one in six men in the U.S...
29 Jul 2010 at 3:00am
Men who develop prostate cancer, especially the more aggressive and dangerous forms that spread throughout the body, tend to retain denser bones as they age than men who stay free of the disease, suggests new research from Johns Hopkins and the National Institute on Aging (NIA), part of the National Institutes of Health...
29 Jul 2010 at 3:00am
Millions of Americans in the early stages of chronic kidney disease (CKD) are at an increased risk of having atrial fibrillation (AF) - a major risk factor for stroke - according to new research by investigators at Wake Forest University Baptist Medical Center...
29 Jul 2010 at 2:00am
Transforming Growth Factor-βa (TGF-β1) Contributes to Kidney Disease Dr...
29 Jul 2010 at 2:00am
Antares Pharma, Inc. (NYSE Amex:AIS) announced positive results from its Phase 3 study of AnturolTM Gel in patients with overactive bladder (OAB). The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied (56 mg daily or 84 mg daily, p=0.028 and 0.033 respectively)...
29 Jul 2010 at 2:00am
Genzyme Corp. (NASDAQ: GENZ) said it welcomed the Centers for Medicare and Medicaid Services' (CMS) decision not to include oral medications without IV equivalents in Medicare's End Stage Renal Disease (ESRD) patient benefit. According to the final rule, these medications, including Genzyme's Renvela® (sevelamer carbonate), will not be included in the bundle until January 1, 2014...
28 Jul 2010 at 2:00pm
Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, announced the start of a U.S. Phase I clinical trial of its biosimilar erythropoietin (EPO) in patients with renal (kidney) dysfunction who have anemia, an important step on the road toward introducing a biosimilar product in the United States...
28 Jul 2010 at 6:00am
Modern Healthcare: Medicare payment for end-stage renal disease care may soon be tied to performance and quality measures if a new proposed rule issued by the Centers for Medicare and Medicaid Services is finalized...
28 Jul 2010 at 4:00am
NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells...
